Home›Companies›Biotech & Pharma›Oculogica

Oculogica, Inc.

Updated Oct 27, 2026·Latest SEC filing May 13, 2024·Suggest an edit

About Oculogica

Oculogica is a private company based in New Richmond, Wisconsin. It has reported $21,979,825 raised in five offerings on Form D since July 2014. Its chief executive is Rosina Samadani.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 26, 2024May 13, 2024$7,569,130of $17.9M target24$315KEquityRule 506(b)Form D ↗
Mar 18, 2022Jun 23, 2022$4,048,963of $4.5M target20$202KEquity, DebtRule 506(b)Form D ↗
Dec 17, 2019Jan 3, 2020$8,071,764of $8.5M target41$196KEquityRule 506(b)Form D ↗
Mar 4, 2016Mar 17, 2016$1,689,998of $2.5M target8$211KEquityRule 506(b)Form D ↗
May 20, 2014Jul 16, 2014$599,970of $999K target6$99,995EquityRule 506(b)Form D ↗
Total, five offerings$21,979,825

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Oculogica's Form D filed May 13, 2024.

JF
KS
RS
Rosina Samadani
Chief Executive Officer and director
JE
Jill Enos
Director
US

Earlier filings also listed Jason Huang (director, last listed Mar 2016), Bilal Khan (director, last listed Mar 2016) and Robert Ritlop (president, last listed Jul 2014).

Sources

  1. SECOculogica, Inc. filing history